Search results
Horphag Research
Nutraingredients.com· 53 minutes agoBased in Geneva, Switzerland Horphag has the exclusive rights to market and sell Pycnogenol® and works with hundreds of companies to help them develop innovative and effective Pycnogenol® product ...
ENDRA Life Sciences Inc (NDRA) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
GuruFocus.com via Yahoo Finance· 3 hours agoQ: What are the expected outcomes from the upcoming FDA pre-submission meeting? A: Michael Thornton, CTO, explained that the focus of the FDA pre-submission meeting would be on aligning < ...
The growth of clinical trials in Africa
Pharmaceutical Technology via Yahoo Finance· 6 days agoClinical trials are growing across Africa as the immense potential of the continent starts to be realised. Sponsors and CROs are tapping into the...
Novavax Stock Just Tripled. Is It Too Late to Buy?
Motley Fool via Yahoo Finance· 32 minutes agoThe company also announced positive clinical-trial data for its combined flu/coronavirus vaccine candidate and aims to launch a phase 3 trial< ...
Oncolytic Virus Therapy Market Size Clinical Trials Sales Forecast 2030
Benzinga· 1 day agoDelhi, May 14, 2024 (GLOBE NEWSWIRE) -- Global Oncolytic Virus Immunotherapy Market Opportunity & Clinical Trials Insight 2030 Report Highlights: Global Oncolytic Virus Immunotherapy Therapy Market Opportunity:
Cassava Sciences posts $25M profit in Q1 amid Alzheimer's trials By Investing.com
Investing.com· 5 days agoCassava Sciences, Inc. (NASDAQ:SAVA), a clinical-stage biotechnology company, announced a profitable...
TiumBio Announces Positive Topline Data from Phase 2a Trial of Merigolix in Patients with Moderate...
WPRI Providence· 7 days agoTiumBio Co., Ltd. (KOSDAQ: 321550), a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutics for patients with rare and incurable ...
More than 20,000 people join search for new dementia treatments
PA Media: Science via Yahoo News· 1 day agoProfessor Patrick Chinnery from the Department of Clinical Neurosciences at the University of...
Cardiol Therapeutics surpasses 85% enrollment in ARCHER trial for acute myocarditis
Proactive Investors· 1 day agoCardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) showcased promising developments in its Phase II ...
EU-X-CT project to clarify cross-border trial access in Europe
Clinical Trials Arena via Yahoo Finance· 5 days agoThe group has already run a public stakeholders' forum in April...ability to do this has the...
